中国P站

Liver transplantation; Surgical technique; Donor criteria; Living donor liver transplantation; Expanded criteria donors; Marginal donors; Graft viability; Postoperative care; Immunosuppression; Graft survival; Ischemia-reperfusion injury; Biliary complications; Anastomosis techniques; Transplant outcomes.

Introduction

Liver transplantation is a life-saving procedure for patients with end-stage liver disease and acute liver failure. Over the past few decades, it has evolved into a highly specialized field with significant advancements in surgical techniques, donor utilization strategies, and postoperative care protocols. These developments have collectively improved short-term survival rates and broadened access to transplantation. However, optimizing long-term outcomes continues to pose significant challenges. Key determinants of transplant success include the surgical procedure itself, the quality and selection of donor organs, and meticulous postoperative management. The balance between these factors is essential for improving patient and graft survival, especially as transplant programs face increasing demands, organ shortages, and complex recipient profiles [1-5].

Description

Surgical technique is central to the success of liver transplantation. While orthotopic liver transplantation (OLT) remains the standard, innovations have refined each phase of the procedure—from vascular anastomosis to bile duct reconstruction—minimizing intraoperative complications and preserving graft function. Technical improvements such as the piggyback technique, which preserves the recipient’s inferior vena cava, and refined arterial reconstruction methods have reduced blood loss, decreased operative times, and improved hemodynamic stability. Additionally, laparoscopic and robotic-assisted donor hepatectomy are becoming increasingly common in living donor liver transplantation (LDLT), offering reduced morbidity and faster recovery for donors.

Equally crucial is the careful selection and optimization of donor organs. As organ shortages persist, transplant centers are increasingly relying on expanded criteria donors (ECDs), including older donors, donors after circulatory death (DCD), and those with fatty livers or infections like hepatitis C. Advances in organ preservation methods, such as machine perfusion, have enhanced the viability of marginal grafts by reducing ischemia-reperfusion injury and allowing functional assessment prior to implantation. These technologies help mitigate risks associated with suboptimal organs and are changing the landscape of donor selection by expanding the usable donor pool without compromising outcomes [6-10].

Discussion

The shift toward utilizing ECDs and the growing practice of LDLT have introduced new challenges that demand skilled surgical execution and robust perioperative management. LDLT, while advantageous in alleviating organ shortages and allowing elective scheduling, requires precise anatomical mapping and graft size optimization to ensure donor safety and recipient viability. Moreover, transplantation with ECD livers necessitates enhanced postoperative surveillance due to higher risks of early allograft dysfunction, biliary complications, and delayed graft function. Innovations in intraoperative imaging and real-time assessment of graft perfusion have improved surgical decision-making and reduced complication rates.

Postoperative care plays an equally critical role in patient recovery and long-term graft survival. Intensive monitoring of hemodynamic status, liver function, coagulation, and renal performance is vital during the immediate post-transplant period. Enhanced recovery after surgery (ERAS) protocols, incorporating multimodal pain management and early mobilization, have reduced ICU and hospital stays while maintaining safety. Furthermore, tailoring immunosuppressive regimens to individual patient risk profiles has become standard practice, reducing the burden of infection, metabolic syndrome, and malignancy associated with traditional regimens. Newer agents such as mTOR inhibitors and biologics targeting co-stimulatory pathways are under investigation for their potential to provide effective immunosuppression with fewer side effects.

The role of multidisciplinary collaboration cannot be overstated. Optimal outcomes require coordination between transplant surgeons, hepatologists, anesthesiologists, intensivists, infectious disease specialists, and transplant pharmacists. Early identification and management of complications such as hepatic artery thrombosis, biliary leaks, and acute rejection are essential to prevent long-term graft loss. Additionally, transplant centers are increasingly utilizing data analytics and predictive models to guide clinical decisions and enhance individualized care pathways.

Conclusion

Liver transplantation has made remarkable strides through continuous innovation in surgical methods, expanding donor eligibility, and refining postoperative management. Balancing these three pillars—technique, donor criteria, and recovery—is essential to meeting the complex demands of modern transplant medicine. As surgical skills and technologies evolve, and as organ preservation and immunological strategies become more sophisticated, outcomes will continue to improve for an increasingly diverse and complex patient population. Ongoing research, multidisciplinary care models, and personalized treatment strategies are critical to sustaining this progress and pushing the boundaries of what is possible in liver transplantation. By aligning technical precision with strategic donor use and comprehensive postoperative care, the future of liver transplantation is poised for continued success and greater accessibility.

References

1. Zieli艅ska K, Kukulski L, Wróbel M, Przyby艂owski P, Rokicka D, et al. (2022) Carbohydrate Metabolism Disorders in Relation to Cardiac Allograft Vasculopathy (CAV) Intensification in Heart Transplant Patients According to the Grading Scheme Developed by the International Society for Heart and Lung Transplantation (ISHLT). Ann Transplant 27: 933420.

   Indexed at, Google Scholar, Crossref

2. Raffa GM, Di Gesaro G, Sciacca S, Tuzzolino F, Turrisi M, et al. (2016) Heart transplant program at IRCCS-ISMETT: Impact of mechanical circulatory support on pre- and post -transplant survival. Int J Cardiol 219: 358-361.

   Indexed at, Google Scholar, Crossref

3. Kitamura S (2012) Heart transplantation in Japan: a critical appraisal for the results and future prospects. Gen Thorac Cardiovasc Surg 60: 639-644.

   Indexed at, Google Scholar, Crossref

4. Delgado JF, Reyne AG, de Dios S, López-Medrano F, Jurado A, et al. (2015) Influence of cytomegalovirus infection in the development of cardiac allograft vasculopathy after heart transplantation. J Heart Lung Transplant 3:1112-1119.

   Indexed at, Google Scholar, Crossref

5. Wever-Pinzon O, Edwards LB, Taylor DO, Kfoury AG, Drakos SG, et al. (2017) Association of recipient age and causes of heart transplant mortality: Implications for personalization of post-transplant management-An analysis of the International Society for Heart and Lung Transplantation Registry. J Heart Lung Transplant 36: 407-417.

   Indexed at, Google Scholar, Crossref

6. Saczkowski R, Dacey C, Bernier PL (2010) Does ABO-incompatible and ABO-compatible neonatal heart transplant have equivalent survival. Interact Cardiovasc Thorac Surg 10: 1026-1033.

   Indexed at, Google Scholar, Crossref

7. Jeewa A, Manlhiot C, Kantor PF, Mital S, McCrindle BW, et al. (2014) Risk factors for mortality or delisting of patients from the pediatric heart transplant waiting list. J Thorac Cardiovasc Surg 147: 462-468.

   Indexed at, Google Scholar, Crossref

8. Conway J, Manlhiot C, Kirk R, Edwards LB, McCrindle BW, et al. Mortality and morbidity after retransplantation after primary heart transplant in childhood: an analysis from the registry of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 33: 241-251.

   Indexed at, Google Scholar, Crossref

9. R D Vanderlaan, C Manlhiot, L B Edwards, J Conway, B W McCrindle, et al. (2015) Risk factors for specific causes of death following pediatric heart transplant: An analysis of the registry of the International Society of Heart and Lung Transplantation. Pediatr Transplant 19: 896-905.

   Indexed at, Google Scholar, Crossref

10. Sivathasan C, Lim CP, Kerk KL, Sim DK, Mehra MR, et al. (2017) Mechanical circulatory support and heart transplantation in the Asia Pacific region. J Heart Lung Transplant 36: 13-18.

    Indexed at, Google Scholar, Crossref